Immunization Safety Review
Measles-Mumps-Rubella Vaccine and Autism
Seiten
2001
National Academies Press (Verlag)
978-0-309-38625-8 (ISBN)
National Academies Press (Verlag)
978-0-309-38625-8 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Immunization is widely regarded as one of the most effective and beneficial tools for protecting the public's health. In the United States, immunization programs have resulted in the eradication of smallpox, the elimination of polio, and the control and near elimination of once-common, often debilitating and potentially life-threatening diseases, including measles, mumps, rubella, diphtheria, pertussis, tetanus, and Haemophilus influenza type b.
Along with the benefits of widespread immunization, however, have come concerns about the safety of vaccines. No vaccine is perfectly safe or effective, and vaccines may lead to serious adverse effects in some instances. Furthermore, if a serious illness is observed after vaccination, it is often unclear whether that sequence is coincidental or causal, and it can be difficult to determine the true nature of the relationship, if any, between the vaccination and the illness. Ironically, the successes of vaccine coverage in the United States have made it more difficult for the public to weigh the benefits and complications of vaccines because the now-controlled diseases and their often-serious risks are no longer familiar. However, because vaccines are so widely used-and because state laws require that children be vaccinated before entering daycare and school, in part to protect others-it is essential that safety concerns be fully and carefully studied.
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism, the first of a series from the Institute of Medicine (IOM) Immunization Safety Review Committee, presents an assessment of the evidence regarding a hypothesized causal association between the measles-mumps-rubella (MMR) vaccine and autism, an assessment of the broader significance for society of the issues surrounding the MMR-autism hypothesis, and the committee's conclusions and recommendations based on those assessments.
Table of Contents
Front Matter
Executive Summary
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Appendix A: Januaray 11, 2001 - Meeting Agenda
Appendix B: March 8, 2001 - Meeting Agenda
Appendix C: Immunization Safety Review Committee Biosketches
Appendix D: Research Needs and Opportunities Related to the Measles-Mumps-Rubella Vaccine and Autism
Along with the benefits of widespread immunization, however, have come concerns about the safety of vaccines. No vaccine is perfectly safe or effective, and vaccines may lead to serious adverse effects in some instances. Furthermore, if a serious illness is observed after vaccination, it is often unclear whether that sequence is coincidental or causal, and it can be difficult to determine the true nature of the relationship, if any, between the vaccination and the illness. Ironically, the successes of vaccine coverage in the United States have made it more difficult for the public to weigh the benefits and complications of vaccines because the now-controlled diseases and their often-serious risks are no longer familiar. However, because vaccines are so widely used-and because state laws require that children be vaccinated before entering daycare and school, in part to protect others-it is essential that safety concerns be fully and carefully studied.
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism, the first of a series from the Institute of Medicine (IOM) Immunization Safety Review Committee, presents an assessment of the evidence regarding a hypothesized causal association between the measles-mumps-rubella (MMR) vaccine and autism, an assessment of the broader significance for society of the issues surrounding the MMR-autism hypothesis, and the committee's conclusions and recommendations based on those assessments.
Table of Contents
Front Matter
Executive Summary
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Appendix A: Januaray 11, 2001 - Meeting Agenda
Appendix B: March 8, 2001 - Meeting Agenda
Appendix C: Immunization Safety Review Committee Biosketches
Appendix D: Research Needs and Opportunities Related to the Measles-Mumps-Rubella Vaccine and Autism
1 Front Matter; 2 Executive Summary; 3 Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism; 4 Appendix A: Januaray 11, 2001 - Meeting Agenda; 5 Appendix B: March 8, 2001 - Meeting Agenda; 6 Appendix C: Immunization Safety Review Committee Biosketches; 7 Appendix D: Research Needs and Opportunities Related to the Measles-Mumps-Rubella Vaccine and Autism
| Verlagsort | Washington |
|---|---|
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
| ISBN-10 | 0-309-38625-X / 030938625X |
| ISBN-13 | 978-0-309-38625-8 / 9780309386258 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
das Manual zur psychologischen Gesundheitsförderung
Buch | Hardcover (2023)
Springer Berlin (Verlag)
CHF 55,95
Wissenschaftlich basierte Empfehlungen, Tipps und Ernährungspläne für …
Buch (2022)
Thieme (Verlag)
CHF 69,95
